Analgesic Effects of Midazolam in Human Volunteers (GabA01)
A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1190
- Schmerzdiagnostik / Clinical Research Unit
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male and female volunteers
- 18-40 years old
- healthy
- body mass index between 5th and 85th percentile
- Caucasian
- non smoker or moderate smoker (<10 cigarettes per day)
- able to understand, write, and read German
Exclusion Criteria:
- acute or chronic pain condition (except for mild day-to-day pain on <5 days/month)
- previous (up to 5 days preceding the study) or current medications prescription or over-the-counter, especially analgesics
- symptoms of a clinically relevant illness in the 2 weeks before the first study day
- hypertension
- any known psychiatric condition
- abuse of alcoholic beverages, drug abuse
- known positive human immunodeficiency virus status
- any known medical condition which may interact with study medication, study objectives, or compliance of subject with study tasks
- participation in a clinical trial in the 4 weeks preceding the study
- known allergy against Midazolam
- known allergy against Fentanyl
- pregnancy or breast-feeding
- unable or unwilling to give informed consent
- unable or unwilling to follow investigator's instructions
- unable or unwilling to comply with study protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Midazolam
Drug: Midazolam (experimental)
|
Other Names:
|
|
Placebo Comparator: Isotonic saline
Drug: Isotonic saline (placebo)
|
|
|
Active Comparator: Fentanyl
Drug: Fentanyl (active comparator)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in pain ratings (0-100) to a suprathreshold heat pain stimulus
Time Frame: 3.5 Minutes after end of infusion
|
3.5 Minutes after end of infusion
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in pain ratings to a suprathreshold electrical pain stimulus
Time Frame: 3.5 Minutes after end of infusion
|
3.5 Minutes after end of infusion
|
|
Increase of pressure pain thresholds (kPa)
Time Frame: Up until 23 Minutes after end of infusion
|
Up until 23 Minutes after end of infusion
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Burkhard Gustorff, Prof.Dr., Wilhelminenspital Vienna
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Adjuvants, Anesthesia
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Fentanyl
- Midazolam
Other Study ID Numbers
Other Study ID Numbers
- GabA01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.